April 19, 2017
US Bioservices selected by TESARO to dispense ZEJULA
Frisco, Texas – US Bioservices, an independent specialty pharmacy and part of AmerisourceBergen, announced today it has been selected by TESARO, Inc. as a specialty pharmacy partner for ZEJULA™ (niraparib). The U.S. Food and Drug Administration approved ZEJULA on March 27, 2017, for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
“With the addition of ZEJULA, US Bioservices strengthens its offerings for women and oncology,” adds Aaron Sathre, Senior Vice President of Client Growth and Development, US Bioservices. “As an independent specialty pharmacy with a dedicated Oncology Patient Support Team, US Bioservices provides high-touch clinical care that is specific to patient needs, conditions and therapies. Our multidisciplinary teams are organized to develop long-standing, collaborative relationships with oncologists, resulting in more integrated care for patients and caregivers.”
AmerisourceBergen is committed to ensuring treatment reaches those who need it most. Company experts partner with manufacturers to design an integrated commercialization solution around individual products and the unique needs of patients, providing end-to-end support for each step of the product and patient journey.
ZEJULA is only available from select specialty pharmacies, in-office dispensing practices, and hospitals.
Physicians may submit prescriptions to US Bioservices via phone (877.757.0667), fax (888.899.0067), ePrescribe or the MyPathpoint Prescriber Portal.
About AmerisourceBergen
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 20,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $145 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.